
The atorvastatin effects on the prevention of contrast-induced acute kidney injury during computed tomography with contrast media
Author(s) -
А. А. Васин,
Olga Iu. Mironova,
Victоr Fоmin
Publication year - 2022
Publication title -
terapevtičeskij arhiv
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.181
H-Index - 14
eISSN - 2309-5342
pISSN - 0040-3660
DOI - 10.26442/0403660.2022.09.201845
Subject(s) - medicine , atorvastatin , acute kidney injury , creatinine , kidney disease , statin , observational study , clinical endpoint , contrast (vision) , intravenous contrast , prospective cohort study , contrast induced nephropathy , computed tomography , contrast medium , urology , radiology , clinical trial , artificial intelligence , computer science , percutaneous coronary intervention , myocardial infarction
To assess the role of atorvastatin to the frequency of contrast-induced acute kidney injury (CI-AKI) in patients with cardiovascular diseases (CVD) undergoing computed tomography (CT) with intravenous contrast media.